Health
Chemical biomarker could be used to better manage treatments for COVID-19 – News-Medical.Net
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage…
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations.
In a new paper in International Journal of Infectious Diseases, medical experts in Italy and Australia examined levels of a chemical called serum amyloid A (SAA), a protein synthesised in the liver which can spike up to 1,000-fold within the first 24-48 hours of an infection.
…
-
General18 hours agoFrom jackaroo to ‘Golden Tonsils’ radio titan: the life and career of John Laws
-
General21 hours agoMajority of Australia’s first Ashes Test squad to feature in Sheffield Shield round four
-
General23 hours agoAustralia beats New Zealand 40-8 to defend Women’s Pacific Cup crown
-
Noosa News6 hours agoMan allegedly exposed himself to teen girls in Newstead, Springfield; Dingo snatches shark on K’gari; BBC boss and news chief quit over Trump video outrage